Strs Ohio decreased its position in USANA Health Sciences, Inc. (NYSE:USNA) by 12.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,600 shares of the company’s stock after selling 1,700 shares during the quarter. Strs Ohio’s holdings in USANA Health Sciences were worth $858,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in USNA. Cubist Systematic Strategies LLC acquired a new position in USANA Health Sciences in the 3rd quarter worth about $189,000. Creative Planning bought a new stake in shares of USANA Health Sciences in the 4th quarter worth approximately $219,000. Hikari Power Ltd bought a new stake in shares of USANA Health Sciences in the 4th quarter worth approximately $255,000. Legal & General Group Plc lifted its position in shares of USANA Health Sciences by 7.6% in the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after acquiring an additional 284 shares during the period. Finally, Trust Co. of Vermont lifted its position in shares of USANA Health Sciences by 482.7% in the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after acquiring an additional 3,900 shares during the period. 44.67% of the stock is owned by institutional investors and hedge funds.
Several research firms recently commented on USNA. Pivotal Research raised their target price on USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. TheStreet cut USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday, February 6th. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Finally, Sidoti cut USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.
Shares of USANA Health Sciences, Inc. (USNA) traded up $1.00 during trading on Thursday, hitting $76.75. The stock had a trading volume of 59,532 shares, compared to its average volume of 91,650. The company has a market capitalization of $1,812.64, a price-to-earnings ratio of 30.06 and a beta of 0.99. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $79.00.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, beating the consensus estimate of $1.00 by $0.11. The company had revenue of $273.11 million for the quarter, compared to the consensus estimate of $258.67 million. USANA Health Sciences had a return on equity of 27.02% and a net margin of 5.97%. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.87 earnings per share. equities analysts forecast that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by Strs Ohio” was originally posted by Week Herald and is the property of of Week Herald. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://weekherald.com/2018/02/15/strs-ohio-trims-stake-in-usana-health-sciences-inc-usna.html.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.